American Association of Individual Investors5d
Why Akebia Therapeutics, Inc.’s (AKBA) Stock Is Up 11.37%
Akebia Therapeutics, Inc.’s AKBA share price has surged by 11.37%, which has investors questioning if this is right time to ...
Akebia slumps after Q4 earnings miss
Akebia Therapeutics (NASDAQ:AKBA), which received an FDA nod for its kidney disease therapy Vafseo last year, traded sharply ...
Seeking Alpha3d
AKBA Akebia Therapeutics, Inc.
a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. Its product pipeline ...
University of Wyoming3y
Bile Esculin Agar
If an organism can hydrolyze esculin in the presence of bile, the product esculetin is formed. Esculetin reacts with ferric citrate (in the medium), forming a phenolic iron complex which turns the ...